Thursday, November 30, 2023
HomeInvestingForesite/OrbiMed Potential Provide, Tang Concerned Too

Foresite/OrbiMed Potential Provide, Tang Concerned Too


Kinnate Biopharma (KNTE) (~$100MM market cap) is a medical stage oncology firm, whereas not fairly a damaged/busted biotech beneath my traditional definition (full white flag on improvement pipeline and announce strategic options), Kinnate did do a restructuring in September which resulted in 70% of their workforce being laid off as KNTE reprioritized their analysis efforts to earlier stage packages.  The corporate just lately reported $180.4MM in money and securities as of 9/30, KNTE guided to having sufficient money runway by means of Q2 2026 within the restructuring announcement, implying an ~$18MM/quarter money burn fee going ahead.

Usually this would not be of curiosity to me, however on 11/13, 46.2% joint homeowners, Foresite and OrbiMed (who’re additionally teaming collectively on a potential Thesus Prescribed drugs (THRX) bid) indicated that they are exploring buying the remaining shares they do not at present personal.  Foresite is a reputable purchaser as they did one thing related with Pardes Biosciences (PRDS), shopping for that damaged biotech for roughly 85% of the online money worth tossing in a CVR for 80% of any proceeds from the sale of the event pipeline.  One thing related right here would end in a ~$2.65 bid right here, or 20% upside and will occur pretty shortly within the subsequent month or two.

In a enjoyable wrinkle (not less than round right here), Kevin Tang has jumped into the fray right here as nicely (he is additionally made a bid for THRX) with 6.3% of the shares.  Within the final 12 months plus, he is been pushing for related low cost of money with a CVR sort offers, as a minority shareholder, guessing he would help one right here as nicely.  Tang’s identified to have interaction with administration, hopefully the added strain will push the board to just accept Foresite/OrbiMed’s forthcoming provide.  Draw back right here is extra just like a speculative merger arbitrage scenario (giant), nonetheless, administration has restricted choices as Foresite included the road once more that they are bored with different strategic transactions.

Disclosure: I personal shares of KNTE

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments